Skip to Main Content

Paper Details

Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.
Am J Pathol
60
2012
ASNS, ASNS protein, CRPC, CRPC cells, DNA copy number, LNCaP, MDA PCa 180-30, androgen, asparagine, asparagine synthetase, asparagine synthetase (ASNS) gene, castration-resistant prostate cancer, castration-resistant stage of prostate cancer, patient, prostate cancer, small-interfering RNAs, transcript, xenografts
Author NameAffiliation
Limei HuThe University of Texas M.D. Anderson Cancer Center
David CogdellThe University of Texas M.D. Anderson Cancer Center
Eleni EfstathiouDepartment of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center
Fred SaadResearch Center, University of Montreal
Tarek A BismarUniversity of Calgary
Nora M NavoneDepartment of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center
Wei ZhangThe University of Texas M.D. Anderson Cancer Center
Wei ZhangThe University of Texas M.D. Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2